Last updated on January 2020

Etokimab in Adult Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)


Brief description of study

A study to evaluate the safety and efficacy multiple doses of Etokimab in subjects with Chronic Rhinosinusitis with Nasal Polyps.

Detailed Study Description

This study is a Phase II, randomized, placebo controlled, double-blind, multi-dose study to evaluate the efficacy and safety of Etokimab in subjects with Chronic Rhinosinusitis with Nasal Polyps.

Clinical Study Identifier: NCT03614923

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.